PGMA‐Based Star‐Like Polycations with Plentiful Hydroxyl Groups Act as Highly Efficient miRNA Delivery Nanovectors for Effective Applications in Heart Diseases
Source abstract
Abstract
Poly(glycidyl methacrylate)-based star-like polycations with rich hydrophilic hydroxyl groups can efficiently transfer miRNA into primary cardiac fibroblasts for effective applications in cardiac diseases, such as inhibition of cardiac fibrosis and hypertrophy. As a service to our authors and readers, this journal provides supporting information supplied by the authors. Such materials are peer reviewed and may be re-organized for online delivery, but are not copy-edited or typeset. Technical support issues arising from supporting information (other than missing files) should be addressed to the authors. Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: RNA Interference and Gene Delivery · MXene and MAX Phase Materials · Advanced biosensing and bioanalysis techniques
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Beijing Advanced Innovation Center for Soft Matter Science and Engineering State Key Laboratory of Chemical Resource Engineering Beijing Laboratory of Biomedical Materials Beijing University of Chemical Technology Beijing 100029 P. R. China
Key Laboratory of Remodeling‐Related Cardiovascular Diseases (Ministry of Education) Beijing Institute of Heart, Lung, Blood Vessel Diseases Beijing Anzhen Hospital Affiliated to Capital Medical University Beijing 100029 P. R. China
Funding
National Natural Science Foundation of China
References (54)
Show source-provided references
1. Bartel D. P. · Cell · 2011 · 116 · 28110.1016/S0092-8674(04)00045-5 ↗
2. 10.1126/science.118384210.1126/science.1183842 ↗
3. 10.1038/ncomms832110.1038/ncomms8321 ↗
4. 10.1038/nature0978310.1038/nature09783 ↗
5. 10.1038/nri270810.1038/nri2708 ↗
6. 10.1038/nmat341510.1038/nmat3415 ↗
7. 10.1158/1078-0432.CCR-12-319110.1158/1078-0432.CCR-12-3191 ↗
8. 10.1038/mtna.2013.1410.1038/mtna.2013.14 ↗
9. 10.1016/j.jconrel.2013.09.01510.1016/j.jconrel.2013.09.015 ↗
10. 10.1083/jcb.20120808210.1083/jcb.201208082 ↗
11. 10.1021/nn400171w10.1021/nn400171w ↗
12. 10.1016/j.tig.2012.10.00810.1016/j.tig.2012.10.008 ↗
13. 10.1016/j.cell.2009.04.02110.1016/j.cell.2009.04.021 ↗
14. 10.1002/adma.20120508810.1002/adma.201205088 ↗
15. 10.1038/nmat320910.1038/nmat3209 ↗
16. 10.1038/mt.2012.7910.1038/mt.2012.79 ↗
17. 10.1002/adhm.20120010910.1002/adhm.201200109 ↗
18. 10.1021/nn500857210.1021/nn5008572 ↗
19. 10.1002/adma.20090401610.1002/adma.200904016 ↗
20. 10.1002/wnan.122810.1002/wnan.1228 ↗
21. 10.1021/ja016062m10.1021/ja016062m ↗
22. 10.1016/j.biomaterials.2009.01.02610.1016/j.biomaterials.2009.01.026 ↗
23. 10.1038/nmat318710.1038/nmat3187 ↗
24. 10.1002/anie.20120392010.1002/anie.201203920 ↗
25. 10.1002/smll.20120248510.1002/smll.201202485 ↗
26. 10.1002/anie.20130189610.1002/anie.201301896 ↗
27. 10.1002/adfm.20120250310.1002/adfm.201202503 ↗
28. 10.1021/bm100309y10.1021/bm100309y ↗
29. 10.1002/smll.20150276010.1002/smll.201502760 ↗
30. 10.1021/bc400115e10.1021/bc400115e ↗
31. 10.1016/j.biomaterials.2014.01.03610.1016/j.biomaterials.2014.01.036 ↗
32. Li R. Q. · ACS Appl. Mater. Interfaces · 2014 · 6 · 3909
33. 10.1021/acsami.5b0273310.1021/acsami.5b02733 ↗
34. 10.1038/am.2015.6710.1038/am.2015.67 ↗
35. 10.1097/MNH.0b013e328354e55910.1097/MNH.0b013e328354e559 ↗
36. 10.1681/ASN.201012130810.1681/ASN.2010121308 ↗
37. 10.1038/mt.2012.3610.1038/mt.2012.36 ↗
38. 10.1016/j.biochi.2013.03.01010.1016/j.biochi.2013.03.010 ↗
39. 10.1038/mt.2013.28810.1038/mt.2013.288 ↗
40. 10.1016/j.jacc.2013.09.04110.1016/j.jacc.2013.09.041 ↗
41. 10.1021/bm301718f10.1021/bm301718f ↗
42. 10.1039/C5PY00819K10.1039/C5PY00819K ↗
43. 10.1016/j.biomaterials.2011.03.00310.1016/j.biomaterials.2011.03.003 ↗
44. 10.1016/j.biomaterials.2013.03.08310.1016/j.biomaterials.2013.03.083 ↗
45. 10.1016/j.biomaterials.2011.09.01110.1016/j.biomaterials.2011.09.011 ↗
46. Kim S. · Pharmacol. Rev. · 2000 · 52 · 1110.1016/S0031-6997(24)01434-0 ↗
47. 10.1161/hy1201.10058910.1161/hy1201.100589 ↗
48. 10.1002/emmm.20100008010.1002/emmm.201000080 ↗
49. 10.1161/01.HYP.25.5.91310.1161/01.HYP.25.5.913 ↗
50. 10.1161/ATVBAHA.112.24970610.1161/ATVBAHA.112.249706 ↗
51. 10.1371/journal.pone.003376610.1371/journal.pone.0033766 ↗
52. 10.18632/oncotarget.262110.18632/oncotarget.2621 ↗
53. 10.1161/HYPERTENSIONAHA.113.0284310.1161/HYPERTENSIONAHA.113.02843 ↗
54. 10.1007/s00395-013-0375-810.1007/s00395-013-0375-8 ↗